Management of Gout
The recommended management for gout includes treating acute flares with low-dose colchicine, NSAIDs, or corticosteroids, followed by urate-lowering therapy (ULT) with allopurinol as first-line treatment, targeting serum uric acid levels <6 mg/dL, along with lifestyle modifications. 1, 2
Acute Gout Flare Management
First-line options (choose based on patient factors):
Oral colchicine
NSAIDs
Corticosteroids (oral, intramuscular, or intra-articular)
Urate-Lowering Therapy (ULT)
Indications for ULT:
- Recurrent gout attacks (≥2 per year)
- Presence of tophi
- Joint damage
- Chronic kidney disease 2
First-line ULT:
- Allopurinol
- Start at 100 mg/day and increase by 100 mg increments every 2-4 weeks 1
- Target serum uric acid <6 mg/dL (360 mmol/L) 1, 2
- For severe gout (tophi, chronic arthropathy, frequent attacks), target <5 mg/dL (300 mmol/L) 1
- Dose adjustment in renal impairment:
- CrCl 10-20 mL/min: 200 mg/day
- CrCl <10 mL/min: ≤100 mg/day 5
Alternative ULT options (if allopurinol is not tolerated or ineffective):
Febuxostat
Uricosuric agents (e.g., probenecid)
Pegloticase
- Reserved for severe, debilitating chronic tophaceous gout when other ULT options fail 1
Important ULT considerations:
- Do not initiate ULT during an acute flare - wait until resolution 2
- Provide prophylaxis when starting ULT to prevent flares:
- ULT should be lifelong 1
- Monitor serum uric acid levels regularly 1
Lifestyle Modifications
- Weight loss for overweight/obese patients 2
- Dietary recommendations:
- Regular moderate physical activity 2
Medication Adjustments
- Consider substituting diuretics if possible 1
- For hypertension, consider losartan (has uricosuric effect) 1, 2
- For hyperlipidemia, consider statins or fenofibrate 1
Common Pitfalls and Caveats
- Failure to provide prophylaxis when starting ULT can lead to increased flares in the first 6 months 2
- Inadequate ULT dosing - many patients require dose titration to reach target uric acid levels 1
- Discontinuing ULT after symptom resolution - ULT should be maintained lifelong 1
- Not adjusting allopurinol dose in renal impairment increases risk of severe hypersensitivity reactions 5
- High-dose colchicine regimens cause significant gastrointestinal side effects in nearly all patients 2
- Targeting serum uric acid <3 mg/dL is not recommended long-term 1
By following this comprehensive approach to gout management, focusing on both acute flare treatment and long-term urate-lowering therapy, patients can achieve better control of their disease and improved quality of life.